Evidence map›Paper›PMID 29382184›Full record

ArticleVeterinary sciences2018

Economic Cost of Ovine Johne's Disease in Clinically Affected New Zealand Flocks and Benefit-Cost of Vaccination.

Milan Gautam, Peter Anderson, Anne Ridler, Peter Wilson, Cord Heuer

Open access · goldAbstract read
In one paragraph

Article in Veterinary sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Paratuberculosis: The Hidden Killer of Small Ruminants.Animals : an open access journal from MDPI · 2021
    Review
  3. Article
  4. Sero-surveillance ofJournal of advanced veterinary and animal research · 2020
    Article
  5. Diagnostic Sequences That DistinguishFrontiers in veterinary science · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Milan GautamEpiCentre, School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand. m.gautam@massey.ac.nz.
Peter AndersonThe Vet Centre Marlborough, Blenheim 7201, New Zealand. pa@vetmarlborough.co.nz.
Anne RidlerSchool of Veterinary Science, Massey University, Palmerston North 4442, New Zealand. a.l.ridler@massey.ac.nz.
Peter WilsonEpiCentre, School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand. p.r.wilson@massey.ac.nz.
Cord HeuerEpiCentre, School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand. c.heuer@massey.ac.nz.
Massey University · NZNelson Marlborough Institute of Technology · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were to estimate the on-fam economic cost of ovine Johne's disease (OJD) based on collected incidence and mortality data, and the benefit-cost of OJD vaccination in typical OJD affected flocks in New Zealand after having vaccinated for a number of years. Owners of 20 sheep breeding and finishing farms known to be clinically affected by ovine Johne's disease in New Zealand participated in the study and were monitored for up to two years. Farms were categorized as fine-wool (Merino, Half-Bred, Corriedale, n = 15), and other breeds (Romney, composite breeds, n = 5). Ovine JD was confirmed by gross- and histo-pathology in 358 ewes culled due to chronic progressive wasting. An additional 228 ewes with low body condition score (BCS), but not targeted for culling, were tested with ELISA to estimate the proportion of OJD in ewes in the lower 5% BCS of the flock. Calculations were done separately for fine-wool and other breeds. Based on the data, mortality due to OJD, its associated cost and the benefit-cost of vaccination were evaluated for a hypothetical farm with 2000 ewes by stochastic simulation. Total ewe mortality was similar in fine-wool and other breeds, but the estimated mortality due to OJD was 2.7 times as high in fine-wool (median 1.8%, interquartile range IQR 1.2-2.7%) than other breeds (median 0.69%, IQR 0.3-1.2%), but with large variation between farms. ELISA results demonstrated fine-wool sheep had a higher seroprevalence than other breeds (39%, 95% CI 18-61% vs. 9%, 95% CI 0-22%). Stochastic modelling indicated that the average annual cost of mortality due to OJD in a flock of 2000 ewes was NZD 13,100 (IQR 8900-18,600) in fine-wool and NZD 4300 (IQR 2200-7600) in other breeds. Vaccinating replacement lambs against OJD may be cost-effective in most flocks when the pre-vaccination annual ewe mortality due to OJD is >1%. To make the best-informed decision about vaccination it is therefore essential for farmers to accurately diagnose OJD to establish incidence.

Indexed as

economicsmortalityNew ZealandOvine Johne’s diseasevaccination

Identifiers

PMID29382184
PMCPMC5876568
OpenAlexW2788091828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.